tm logo
XIPERE
Live/Registered
REGISTERED

on 15 Mar 2022

Last Applicant/ Owned by

900 North Point Parkway

Alpharetta

GA

30005

Serial Number

87896124 filed on 27th Apr 2018

Registration Number

6672372 registered on 15th Mar 2022

in the Principal Register

Correspondent Address

Bassam N. Ibrahim

BUCHANAN INGERSOLL & ROONEY PC

Suite 500

1737 King Street

Alexandria VA 22314-2727

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XIPERE

Ocular pharmaceuticals; ophthalmic preparations Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems

Classification Information


Class [005]
Pharmaceutical Products


Ocular pharmaceuticals; ophthalmic preparations


First Use Date in General

13th Dec 2021

First Use Date in Commerce

13th Dec 2021

Class [010]
Medical Instrument Products


Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems


First Use Date in General

13th Dec 2021

First Use Date in Commerce

13th Dec 2021

Mark Details


Serial Number

No 87896124

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 0080003-102

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Apr 2022TEAS SECTION 7 REQUEST RECEIVED
15th Mar 2022REGISTERED-PRINCIPAL REGISTER
09th Feb 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th Feb 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08th Jan 2022STATEMENT OF USE PROCESSING COMPLETE
06th Jan 2022USE AMENDMENT FILED
06th Jan 2022TEAS STATEMENT OF USE RECEIVED
17th Sep 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Sep 2021EXTENSION 5 GRANTED
14th Sep 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL